Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-21 8:27 pm Purchase | 13G | iTeos Therapeutics Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 2,325,000 6.400% | 1,065,524 (+84.60%) | View |
| 2024-11-19 09:57 am Unchanged | 13D | iTeos Therapeutics Inc. ITOS | Boxer Capital Management LLC | 1,020,052 2.800% | 0 (Unchanged) | View |
| 2024-11-18 9:57 pm Purchase | 13D | iTeos Therapeutics Inc. ITOS | Boxer Capital Management LLC | 1,020,052 2.800% | 1,020,052 (New Position) | View |
| 2024-11-14 6:04 pm Sale | 13G | iTeos Therapeutics Inc. ITOS | EcoR1 Capital LLC | 1,608,616 4.400% | -336,056 (-17.28%) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | iTeos Therapeutics Inc. ITOS | BlackRock Inc. BLK | 3,882,549 10.600% | 0 (Unchanged) | View |
| 2024-10-21 4:11 pm Sale | 13G | iTeos Therapeutics Inc. ITOS | BlackRock Inc. BLK | 3,882,549 10.600% | -379,196 (-8.90%) | View |
| 2024-10-15 9:49 pm Purchase | 13D | iTeos Therapeutics Inc. ITOS | Boxer Capital LLC | 3,020,052 8.100% | 73,137 (+2.48%) | View |
| 2024-10-15 7:20 pm Unchanged | 13D | iTeos Therapeutics Inc. ITOS | Boxer Asset Management Inc. | 0 0.000% | 0 (Unchanged) | View |
| 2024-09-30 09:00 am Purchase | 13G | iTeos Therapeutics Inc. ITOS | TANG CAPITAL MANAGEMENT LLC | 2,407,800 6.600% | 2,407,800 (New Position) | View |
| 2024-05-15 08:37 am Purchase | 13D | iTeos Therapeutics Inc. ITOS | Boxer Capital LLC | 2,946,915 8.100% | 792,857 (+36.81%) | View |
| 2024-05-14 9:10 pm Sale | 13D | iTeos Therapeutics Inc. ITOS | RA CAPITAL MANAGEMENT L.P. | 3,659,046 9.990% | -758,213 (-17.16%) | View |
| 2024-02-16 12:54 pm Purchase | 13G | iTeos Therapeutics Inc. ITOS | EcoR1 Capital LLC | 1,944,672 5.400% | 1,944,672 (New Position) | View |
| 2024-02-14 09:45 am Sale | 13G | iTeos Therapeutics Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,259,476 3.500% | -551,359 (-30.45%) | View |
| 2024-02-13 5:08 pm Sale | 13G | iTeos Therapeutics Inc. ITOS | VANGUARD GROUP INC | 1,490,942 4.170% | -328,088 (-18.04%) | View |
| 2024-01-23 4:13 pm Sale | 13G | iTeos Therapeutics Inc. ITOS | BlackRock Inc. BLK | 4,261,745 11.900% | -217,676 (-4.86%) | View |
| 2024-01-09 4:26 pm Sale | 13G | iTeos Therapeutics Inc. ITOS | MILLENNIUM MANAGEMENT LLC | 967,402 2.700% | -1,123,431 (-53.73%) | View |
| 2023-10-24 4:12 pm Purchase | 13G | iTeos Therapeutics Inc. ITOS | MILLENNIUM MANAGEMENT LLC | 2,090,833 5.800% | 2,090,833 (New Position) | View |
| 2023-02-14 10:08 am Sale | 13G | iTeos Therapeutics Inc. ITOS | RTW INVESTMENTS LP | 0 0.000% | -2,353,015 (Position Closed) | View |
| 2023-02-13 6:14 pm Sale | 13G | iTeos Therapeutics Inc. ITOS | BIOTECHNOLOGY VALUE FUND L P | 1,810,835 5.100% | -118,366 (-6.14%) | View |
| 2023-02-09 11:22 am Purchase | 13G | iTeos Therapeutics Inc. ITOS | VANGUARD GROUP INC | 1,819,030 5.110% | 1,819,030 (New Position) | View |